Developing therapies to
halt the progression of
neurodegenerative disease.
Our target and drug discovery platform is designed to recapitulate key aspects of human neurodegenerative biology by combining four integrated systems:
Analytics: Derive new biological insights from small and sparse data sets
Network Biology: Map progression-associated signals to prioritize disease drivers
Human iPS Cells: Recapitulate progression in vitro with a complex system that includes mature, aged cells
Chemistry & Screening: Mechanism-linked phenotypic assays to go from target to lead
